AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06654596 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Glucocorticoid
Description: Patients in glucocorticoid group will be treated with ACEI/ARB and glucocorticoid ( prednisone/prednisolone) 0.5mg/kg (maximum 40mg/d). After 8 weeks, reduce the dosage by 5 mg per month for a total of 28-40 weeks.
Study NCT06594458 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Observation of newborn with respiratory distress in the delivery room
Description: Newborn manifesting tachypnea or respiratory distress at birth (that responds to supplementary oxygen with FiO2 \<30% and without the need for mechanical ventilation) are placed in a preheated incubator with the required oxygen concentration (if necessary) and carefully monitored by medical and nursing clinicians. A clinical evaluation will be carried out every 15 minutes, with the detection of vital parameters. In case of clinical improvement and suspension of oxygen therapy, the newborn will be transferred to the Neonatal Observation Ward to perform multiparameter monitoring of vital signs up to 6 hours of life and then be reunited with the mother. In case of clinical worsening, a bedside thoracic ultrasound will be carried out and depending on the result and the lung ultrasonography score, it will be evaluated whether to continue the observation in the delivery room or to admit the newborn in the Neonatal Care, Neonatal Sub-Intensive Care or Neonatal Intensive care Units
Study NCT06597136 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diaphragmatic kinesiology taping
Description: The taping on the diaphragm from the abdomen was performed when the participant was standing and breathed-out and the body was in extension. The base of the tape was about 1 inch below the xiphoid process area. Then the arms were lifted above the head and, with maximum deep inspiration and after maximum rib cage expansion, the tails were applied with 10% tension on the rib cage. Diaphragmatic kinesiology taping will be applied in addition to conventional treatment for 3 days.
Study NCT06597136 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Accessory respiratory muscle kinesiology taping
Description: Tapings of the accessory inspiratory muscles were applied in a sitting posture. Sternocleidomastoideus taping was applied when the neck of the participant was in lateral flexion to the opposite side to be taped and in rotation to the same side; and anterior and medius scalene tapings were applied when the neck of the participant was in the lateral flexion position to the opposite side to be taped. Tapings were repeated on the opposite side.Taping was applied to accessory expiratory muscles in the supine position. While the participant was supporting one leg in the hip and knee flexion position on the bed, the other leg was extended from the bed and the hip was kept in the extension position. The obliquus externus muscle was taped on the side with hip-knee flexion and the obliquus internus muscle was taped on the side with hip extension.In addition to conventional treatment, kinesiology taping will be applied to the accessory respiratory muscles for 3 days.
Study NCT06597136 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham kinesiology taping
Description: Sham kinesiology taping will be applied for 3 days. Sham KT was performed with the same taping material. A 2-blocked I strip was applied vertically to the sternum. The same procedures were followed.
Study NCT06600984 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: whole body vibration
Description: On a vibration platform, the children went into a complete squat. The device was calibrated at a frequency of 30 Hz, an amplitude of 2 mm, and a duration of 5 minutes. After the vibration was turned on, the children were told to stay in the squatting position and to report any discomfort that could occur. The vibration automatically shut off after five minutes. The children then rested for a minute. Next, under the identical conditions as for the squatting position, they were instructed to stand on the vibration platform for five minutes with the therapist\&#39;s assistance. Consequently, WBV was applied for a total of 10 minutes during each session.
Study NCT06600984 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: designed physiotherapy program
Description: structured therapeutic exercise program that included neurodevelopmental approaches, balance exercises, milestone facilitation, stretching exercises, and postural reaction facilitation. The program was conducted for one hour each day, three days a week.
Study NCT06598566 — intervention group
Intervention type: OTHER
Intervention: Nottingham Hip Fracture Score (NHFS) score
Description: Nottingham Hip Fracture Score (NHFS) score in patients above 60 years undergoing hip fracture surgery.
Study NCT06598566 — intervention group
Intervention type: OTHER
Intervention: Acute Physiology and Chronic Health Evaluation (APACHE)-II score
Description: Acute Physiology and Chronic Health Evaluation (APACHE)-II score in patients above 60 years undergoing hip fracture surgery
Study NCT06590103 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physically Active Lessons
Description: Physically active learning: this type of intervention is carried out once a week for 1 hour outside the classroom. The teachers of the corresponding subject (with the support of the Physical Education teacher) are in charge of designing and delivering the physically active classes.
Study NCT06594692 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Node-Sparing Short-Course Radiotherapy Combined with CAPOX and Sintilimab
Description: Radiotherapy Protocol:~Short-course radiotherapy using three-dimensional conformal or intensity-modulated radiation therapy techniques. The radiation field will be limited to the tumor bed of the primary colon lesion, excluding surrounding draining lymph nodes and enlarged lymph nodes. The dose is fractionated as 5Gy per fraction, for a total of 25Gy over 5 fractions. Titanium clips will be placed on the proximal and distal ends of the colonic lesion via colonoscopy to guide radiation therapy positioning.~Chemotherapy Protocol (CAPOX Regimen):~1. Oxaliplatin: 130 mg/m², administered intravenously (ivgtt), on day 1 (d1).~2. Capecitabine: 1000 mg/m², orally (po), twice daily (bid), from day 1 to day 14 (d1-14).~Immunotherapy Protocol:~During preoperative treatment, Sintilimab (immune checkpoint inhibitor) will be administered concurrently with each chemotherapy cycle.
Study NCT06594692 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: CAPOX Chemotherapy
Description: Participants will receive 4 cycles of CAPOX chemotherapy followed by radical total mesorectal excision surgery, and then 4 additional cycles of postoperative CAPOX chemotherapy.
Study NCT06591650 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: gemcitabine hydrochloride
Description: 800 mg/m\^2, intravenous (IV) over 30 minutes, Days 1,8, every 21 days.
Study NCT06591650 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: 25 mg/m\^2, intravenous (IV) over 60 minutes, Days 1,8, every 21 days.
Study NCT06591650 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel
Description: 100 mg/m\^2, intravenous (IV) over 30 minutes, Days 1,8, every 21 days.
Study NCT06591650 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: 1500mg, intravenous (IV) over 30 minutes, Days 1, every 21 days.
Study NCT06586450 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low level laser therapy
Description: The participants will receive Low Level Laser on lumbo-pelvic region for 20 min/sessions,3 sessions / week for 12 weeks, with the following parameters: Wavelength: 808 nm, continuous mode, Output power: 160 mw, Penetration depth: 4 cm, Power density:0.16 J/cm2.
Study NCT06586450 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Interferential current
Description: All participants will receive interferential current on lumbopelvic region ( quadripolar technique) for 25 min/session, 3 sessions/week for 12 weeks, with the following parameters: carrier frequency of 4 KHZ and sweep frequency 95 HZ, intensity based on patient's tolerance without muscle contraction.
Study NCT06586450 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Core stability exercise
Description: The participants will perform core stability exercises for 15 min 3 time/week in the form of Prone Gluteal Squeezes, Pelvic Bridging, Curl Up Exercise, and Double Knee to Chest Stretching Exercises.
Study NCT06586450 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Core stability exercise
Description: The participants will perform core stability exercises for 15 min 3 time/week in the form of Prone Gluteal Squeezes, Pelvic Bridging, Curl Up Exercise, and Double Knee to Chest Stretching Exercises.
Study NCT06655519 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CAR-T（RD140 injection）
Description: This study is divided into two stages: dose escalation and dose extension. The dose escalation stage sampled the 3+3 dose-escalation design, and set up three dose-increasing dose groups of 1.0×10\^5 CART cells/kg, 3.0×10\^5 CART cells/kg and 6.0×10\^5 CART cells/kg, and subjects will receive a single infusion of RD140. Each dose group level will include 3-6 subjects.~In the dose expansion stage, 1\~2 dose groups were selected for expansion and 3\~6 subjects were included in each extended dose group, and the target dose was administered once.
Study NCT05601947 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Structured Proprioception and Closed Kinetic Chain Exercises Group
Description: In this group, an exercise program consisting of 3 stages, ranging from simple to difficult and including closed kinetic chain exercises and proprioceptive exercises, will be applied.
Study NCT05601947 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Wii Based Balance Training Program Group
Description: In addition to electrotherapy and conventional exercise program, wii-based balance training program will be applied 5 days a week for 3 weeks. Balance Surf, which includes lateral weight transfer, Balance Adventure, which includes versatile balance exercises, and balance bowling for static and dynamic postural control will be implemented in the Fizyosoft Balance System. Each game will be practiced under the supervision of a physiotherapist for a total of 3 minutes, respectively, Balance surf, Balance adventure, Balance surf, Balance bowling and Balance surf, for a total of 15 minutes.
Study NCT06300385 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electromyostimulation
Description: Electromyostimulation (EMS), a low-frequency current, will be used for electrical stimulation of the wrist flexor muscle group. Stimulation frequency will be applied as 25 Hertz. Care will be taken to ensure that the current intensity does not cause pain in the patient. The size of the EMS electrodes is 2 cm2 and they will be placed in the form of 4 electrodes on the wrist flexor muscles (inner wrist area) with a distance of 1 cm between them. Each strengthening session will be 15 minutes for 6 weeks, 3 days a week, for a total of 18 sessions. EMS application will be carried out together with strengthening exercises. Laica MD6078 branded device belonging to the researchers will be used.
Study NCT06300385 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Strengthening exercises
Description: All participants will do resistance exercises for strengthening, 3 sessions per week for 6 weeks. Each movement will be performed in 3 sets and 12 repetitions according to the planned intensity. Wrist curl, reverse wrist curl movements (with 10kg dumbbells) and power web flex grip movements will be applied simultaneously with EMS application. The program will last 15 minutes in total.
Study NCT06300385 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Strengthening exercises
Description: All participants will do resistance exercises for strengthening, 3 sessions per week for 6 weeks. Each movement will be performed in 3 sets and 12 repetitions according to the planned intensity. Wrist curl, reverse wrist curl movements (with 10kg dumbbells) and power web flex grip movements will be applied simultaneously with EMS application. The program will last 15 minutes in total.
Study NCT05714748 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: EBV mRNA vaccine
Description: With 20ug as the starting point, the dose was increased using a dose escalation scheme. Each subject only received one corresponding dose, and intramuscular injection was administered again every 7 days, and after 4 doses, the 5th dose was given after 1 month interval
Study NCT05997368 — intervention group
Intervention type: OTHER
Intervention: Survey1
Description: As a research, it was planned to be a quantitative research. Data collection will be conducted through online and face-to-face surveys. Scales and forms to be found and used in the research: The Pain Beliefs Questionnaire-PBQ, Numerical Rating Scale (NRS-11) and The Central Of Pain Scale-COPS. By handing out the paper format to the participants and uploading it to the Google Forms system online, it can be downloaded from mail, social media or mobile phone applications such as message, Mail, etc. They will be asked to participate in the study by accessing
Study NCT05997368 — intervention group
Intervention type: OTHER
Intervention: Survey2
Description: As a research, it was planned to be a quantitative research. Data collection will be conducted through online and face-to-face surveys. Scales and forms to be found and used in the research: The Pain Beliefs Questionnaire-PBQ, Numerical Rating Scale (NRS-11) and The Central Of Pain Scale-COPS. By handing out the paper format to the participants and uploading it to the Google Forms system online, it can be downloaded from mail, social media or mobile phone applications such as message, Mail, etc. They will be asked to participate in the study by accessing
Study NCT05997368 — intervention group
Intervention type: OTHER
Intervention: Survey3
Description: As a research, it was planned to be a quantitative research. Data collection will be conducted through online and face-to-face surveys. Scales and forms to be found and used in the research: The Pain Beliefs Questionnaire-PBQ, Numerical Rating Scale (NRS-11) and The Central Of Pain Scale-COPS. By handing out the paper format to the participants and uploading it to the Google Forms system online, it can be downloaded from mail, social media or mobile phone applications such as message, Mail, etc. They will be asked to participate in the study by accessing
Study NCT06389955 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TP 3654
Description: TP 3654 is an investigational orally delivered drug
Study NCT06601595 — intervention group
Intervention type: DRUG
Intervention: TNF inhibitors
Description: tumour necrosis factor inhibitors approved as treatments for ulcerative colitis and/or Crohns disease
Study NCT06601595 — intervention group
Intervention type: DRUG
Intervention: conventional ibd medical treatment
Description: Conventional therapies for ulcerative colitis and Crohns disease (CD) include aminosalicylates, corticosteroids, thiopurines, methotrexate other than anti-tumor necrosis factor agents.
Study NCT05074290 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epidiferphane
Description: During the phase I portion of the study, subjects will be assigned to take either two (half target dose) or four (full target dose) Epidiferphane tablets orally three times daily following a 3 + 3 design. Three subjects will be sequentially enrolled at each of the 2 dose levels (beginning with the half target dose) until at least one dose-limiting toxicity (DLT) occurs. Dosing escalation will be stopped if two or more DLTs occur at either dose level. The maximum tolerated dose will be one dose level lower than the dose level at which 2 or more DLTs occur. Dose escalation will occur separately for each taxane regimen (docetaxel or paclitaxel).~All subjects in the phase II portion of the study will receive the maximum tolerated dose determined in the phase I portion of the study for their taxane regimen.~Subjects in both portions of the study will receive treatment with Epidiferphane for a maximum of three months.
Study NCT05074290 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Taxane Chemotherapy
Description: All subjects on both phases of the study will be concurrently treated with a taxane regimen containing either paclitaxel given weekly, nab-paclitaxel given weekly or every 3 weeks or docetaxel given every 3 weeks. The choice of taxane regimen will be determined by the treating physician prior to consenting to participate in this trial.
Study NCT06603389 — intervention group
Intervention type: OTHER
Intervention: Psychiatric Non-Suicidal Self-Injury Risk Assessment Scale
Description: sacles or questionnaires
Study NCT06596837 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: virtual reality
Description: The investigators manipulated the following two variables within the experimental design:~Immersion in the virtual environment. This was a nominal variable with two levels: a low-immersive environment (Other group) and a highly immersive environment (Experimental group) using the Cold River application.~Order of virtual reality (VR) deployment during the first session. This was also a nominal variable with two levels: VR during the first part of the dressing change (removing the dressing) and VR during the second part of the dressing change (cleaning the wound and applying a new dressing). In each subsequent session, the order of VR deployment was swapped for each participant.~The values of both variables were assigned to participants according to their numbers (e.g., 1. highly immersive, VR first; 2. low immersive, VR first; 3. highly immersive, VR last; 4. low immersive, VR last, etc.).
Study NCT06596837 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: virtual reality
Description: The investigators manipulated the following two variables within the experimental design:~Immersion in the virtual environment. This was a nominal variable with two levels: a low-immersive environment (Other group) and a highly immersive environment (Experimental group) using the Cold River application.~Order of virtual reality (VR) deployment during the first session. This was also a nominal variable with two levels: VR during the first part of the dressing change (removing the dressing) and VR during the second part of the dressing change (cleaning the wound and applying a new dressing). In each subsequent session, the order of VR deployment was swapped for each participant.~The values of both variables were assigned to participants according to their numbers (e.g., 1. highly immersive, VR first; 2. low immersive, VR first; 3. highly immersive, VR last; 4. low immersive, VR last, etc.).
Study NCT06597071 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: NeuraLight PD
Description: NeuraLight software-based platform for PD patients
Study NCT06597071 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: NeuraLight PSP
Description: NeuraLight software-based platform for PSP patients
Study NCT06597071 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: NeuraLight MSA
Description: NeuraLight software-based platform for MSA patients
Study NCT06597071 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: NeuraLight
Description: NeuraLight software-based platform
Study NCT06591611 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: PEEK reinforced fixed all-on-four prosthesis
Description: Fabricating a fixed prosthesis for patients with completely edentulous mandibles reinforced with PEEK
Study NCT06591611 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PEEK reinforced fixed all-on-four prosthesis
Description: Fabricating a fixed prosthesis for patients with completely edentulous mandibles reinforced with PEEK
Study NCT06601023 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychosocial intervention
Description: The PM+MiLE is a low-intensity intervention. The intervention will cover relevant aspects of brief mindfulness, legal education, awareness of human rights and challenges of complaint, including support. The problem management ambit will include understanding adversity, managing stress, managing problems, getting going and keep doing, strengthening social support and staying well and looking forward, including positive behaviour modification.The intervention will also incorporate child development and building positive parenting interactions with children.
Study NCT06597669 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Placement of stainless steel crowns on primary molars
Description: Preformed metal crowns have been placed to treat caries in primary molars
Study NCT06594874 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HS-10370
Description: HS-10370 administered orally every day
Study NCT06594874 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab
Description: Administered intravenously every 21 days; dose by label.
Study NCT06594874 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Administered intravenously every 21 days; dose by label.
Study NCT06594874 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Administered intravenously every 21 days; dose by label.
Study NCT06594874 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: Administered intravenously every 21 days; dose by label.
Study NCT06588036 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prebiotic
Description: . The primary outcome measure will be the mean time from the initiation of treatment to the resolution of diarrhea symptoms. This objective seeks to provide evidence-based insights into the optimal management strategies for childhood diarrhea and inform clinical practice guidelines.
Study NCT06588036 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Duration
Description: every participant is alloted a group based on RCT.
Study NCT06588036 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Smecta
Description: Group 4 will be given smecta scahet
Study NCT06587815 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: musical starry sky projector
Description: Children in intervention group received musical starry sky projector during their sleep time
Study NCT06591845 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ziresovir 125 mg
Description: Active Substance: Ziresovir, Pharmaceutical Form: Suspension, Route of Administration: Oral